|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Mindray Medical International Ltd. has become the latest Chinese company to delist from an American exchange after completing a $1.9 billion privatization deal as a record wave of buyouts continues this ...
Bottom line: The looming completion of buyouts for Qihoo 360 and Mindray Medical points to growing momentum for successful privatizations of other Chinese firms waiting to de-list from New York. Two of the largest in a wave of privatizations by US-listed Chinese firms have just taken big steps forward, with major
Click here to see latest analysisMindray Medical International Ltd. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of Mindray Medical International Ltd. – Stryker Corporation, Vascular Solutions, Inc., OraSure Technologies, Inc. and Boston Scientific Corporation (SYK-US, VASC-US, OSUR-US and BSX-US) that have also reported for […] (Read more...) The post Mindray Medical International Ltd. Earnings Q3, 2015 appeared first on CapitalCube.